Quick Summary
Rybelsus 14mg Tablet
Last updated on 25 Jun 2026 | 06:53 AM (IST)
₹3085
MRP: ₹3628.12
(You Save ₹543.12)
10 TABLET(s) IN A STRIP
Rybelsus 14mg Tablet is an oral prescription medicine used to manage type 2 diabetes in adults by helping control blood sugar levels. It contains semaglutide, which works by activating GLP-1 receptors to increase insulin secretion and reduce glucose production. Rybelsus is used under medical supervision as part of a comprehensive diabetes management plan that includes diet and lifestyle changes.
15% OFF
₹3085
MRP: ₹3,628.12
Inclusive of all taxes
15% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Obeda 14mg Tablet
DR REDDY'S LABO...
₹ 202.50/tablet
34% cheaper
Sembolic 14 Tablet
TORRENT PHARMAC...
₹ 228.60/tablet
25% cheaper
Semalix 14 Tablet
TORRENT PHARMAC...
₹ 228.60/tablet
25% cheaper
Introduction
Rybelsus 14mg tablet contains active components such as Semaglutide. This medication belongs to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). This medication treats type 2 diabetes by lowering blood sugar levels and promoting weight loss. It also reduces the risk of cardiovascular events in high-risk diabetes patients. It can be combined with other diabetes medications for better control and may lower blood pressure, benefitting cardiovascular health. Additionally, it shows potential in protecting kidneys and slowing diabetic kidney disease progression.
You should not take Rybelsus 14mg tablet if you have a known hypersensitivity to this medication or any of its components. People with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2) should not take this medication. It is not approved for use in pediatric patients with type 2 diabetes. It should not used in individuals with a history of severe gastrointestinal disease, such as gastroparesis. This medication is not recommended for individuals with severe renal impairment or end-stage renal disease. rybelsus 14 mg price varies by retailer and location.
Uses
rybelsus 14 mg uses to treat the following:
- Type 2 diabetes mellitus
- Obesity or overweight.
How Rybelsus 14mg Tablet Works
Rybelsus 14mg tablet, a GLP-1 receptor agonist, exerts its therapeutic effects by mimicking the action of the naturally occurring hormone GLP-1. In diabetes management, this medication enhances insulin secretion, inhibits glucagon release, slows gastric emptying, and decreases hepatic glucose production. This medication effect leads to improved glycemic control and reduced HbA1c levels. Additionally, this medication promotes weight loss through increased satiety, decreased food intake, and modulation of gastric function. It has also demonstrated cardiovascular benefits, including a potential reduction in major cardiovascular events.
Interaction of Rybelsus 14mg Tablet with other drugs
Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Rybelsus 14mg tablet, reducing effectiveness by causing undesirable side effects.
Storage Conditions
Rybelsus 14 mg storage instructions are:
- Stored in a refrigerator from 2°C to 8°C.
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep away from children and pets.
How to take Rybelsus 14mg Tablet
Rybelsus 14mg tablet is typically administered as a subcutaneous injection. The injection can be given in the abdomen, thigh, or upper arm. These medication pens come with clear instructions on how to load the needle, dial the dose, and administer the injection. After injecting, dispose of the needle safely in a sharps container. Regular monitoring and follow-up with your healthcare provider are important to assess your progress and make any necessary adjustments to your treatment plan.
Safety Advice for Rybelsus 14mg Tablet
Breast Feeding
If you are breastfeeding, consult your healthcare provider before using Rybelsus 14mg tablet, as its efficacy and safety in breastfeeding are unknown.
Alcohol
Alcohol can affect blood sugar levels and potentially interfere with diabetes management. Consult your healthcare provider regarding alcohol consumption while using Rybelsus 14mg tablet.
Liver
Rybelsus 14mg tablet should be used cautiously in individuals with severe liver disease. If you have any lung or liver conditions, discuss the risks and benefits of Rybelsus 14mg tablet with your healthcare provider before starting treatment.
Lungs
Rybelsus 14mg tablet should be used cautiously in individuals with severe lung disease. If you have any lung or lung conditions, discuss the risks and benefits of Rybelsus 14mg tablet with your healthcare provider before starting treatment.
Driving
Rybelsus 14mg tablet is not known to cause drowsiness or impair cognitive function. However, if you experience any side effects that may affect your ability to drive or operate machinery, such as dizziness or hypoglycemia (low blood sugar), use caution and consult your doctor.
Pregnancy
Rybelsus 14mg tablet is not recommended if you are pregnant or planning to become pregnant, consult your healthcare provider before using it.
Side Effects
rybelsus 14 mg side effects like all medications, although not everyone will experience them.
Serious
- Allergic reactions
- Pancreatitis (abdominal pain, nausea, vomiting)
- Hypoglycemia (low blood sugar)
- Kidney problems (changes in urination, swelling in the ankles or feet)
- Thyroid C-cell tumors
Common
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Abdominal pain
- Decreased appetite
- Headache
- Fatigue
- Injection site reactions (e.g., redness, pain, itching)
Expert tips
-
Discuss your medical history with your doctor, especially if you have pancreatitis, thyroid, kidney, liver, or gallbladder issues.
-
Monitor blood sugar levels regularly to avoid hypoglycemia, particularly when taking other antidiabetic medications.
-
Follow the prescribed rybelsus 14 mg dosage and injection schedule, rotate injection sites, and report any unusual symptoms like abdominal pain or skin reactions.
-
Pregnant or breastfeeding women should consult a doctor before use, and attend follow-up appointments to monitor overall health while on treatment.
FAQs about Rybelsus 14mg Tablet
Q1.
What are the common side effects of Rybelsus 14mg tablet?
Common side effects may include nausea, vomiting, diarrhea, decreased appetite, headache, and injection site reactions.
Q2.
Can Rybelsus 14mg tablet cause Pancreatitis?
There is a potential risk of pancreatitis with Rybelsus 14mg tablet. Seek medical attention if you experience severe abdominal pain.
Q3.
Who should not use Rybelsus 14mg tablet?
Rybelsus 14mg tablet is contraindicated in individuals with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2). Those with a hypersensitivity to this medication should also avoid its use.
Q4.
Can Rybelsus 14mg tablet affect my thyroid health?
Yes, Rybelsus 14mg tablet has been associated with thyroid C-cell tumors in animal studies. Individuals with a history of thyroid conditions or MTC should discuss the potential risks with their healthcare provider.
Q5.
Is Rybelsus 14mg tablet safe for individuals with kidney problems?
Rybelsus 14mg tablet should be used cautiously in individuals with kidney impairment. Dose adjustments may be necessary based on your kidney function.
Q6.
What should I do if I develop gallbladder symptoms while taking Rybelsus 14mg tablet?
Rybelsus 14mg tablet has been associated with gallbladder-related events. Seek medical attention if you experience symptoms like sudden abdominal pain, particularly in the upper right side.
Q7.
Can Rybelsus 14mg tablet be used with other GLP-1 medications?
No, Rybelsus 14mg should generally not be used together with other GLP-1 medications. Combining multiple GLP-1 therapies can increase the risk of side effects such as nausea, vomiting, or low blood sugar. Always consult your doctor before making any changes to your treatment.
Fact Box
Molecule name: | Semaglutide |
Therapeutic class: | Hypoglycemic Drug |
Pharmacological class: | Glucagon-like peptide-1 (GLP-1)receptor agonists |
Indications: | 1. Type 2 diabetes mellitus 2. Obesity or overweight |
References
Novo Nordisk Inc, FDA Food and Drug Safety Administration [September 20, 2019] [Accessed date 18th August 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213051s000lbl.pdf
Novo Nordisk Limited, EMC, [25 Jan 2023], [Accessed date 18th August 2023] Electronic Medicines Compendium (EMC), [Revised on 25th Jan 2023] [Accessed on 18 August 2023] https://www.medicines.org.uk/emc/product/11507/pil
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Archana Gupta
BDS
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 25 Jun 2026 | 06:53 AM (IST)
Want to know more?
Read Our Editorial Policy
